Dr. Tsilidis is a Senior Lecturer in Cancer Epidemiology in the Department of Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine of Imperial College. He also holds an Assistant Professor position in Epidemiology at the University of Ioannina School of Medicine in Greece.
He was trained at the University of Athens, where he received a Bachelor's in Nursing and a Master's in Public Health, and at the School of Public Health of the Johns Hopkins University in Baltimore, USA, where he received a Master of Health Science in Biostatistics and PhD in Epidemiology. He performed his post-doctoral training at the University of Oxford in the UK. He has received more than 20 awards/scholarships during his training and research career from national and international bodies (e.g., American Association for Cancer Research, Johns Hopkins School of Public Health, J. William Fulbright Foundation, Gerondelis Foundation, Netherlands Institute for Health Sciences, Hellenic State Scholarship Foundation, University of Athens), and his research has been funded by seven national and international funding programs (e.g., World Cancer Research Fund, European Union, General Secretariat for Research and Technology - Hellenic Ministry of Education, Johns Hopkins School of Public Health), five of which as the principal investigator.
His research interests focus in cancer epidemiology, particularly the etiognosis and prevention of colorectal and prostate cancer, in genetic epidemiology, pharmaco-epidemiology, meta-analysis, and the methodological assessment and correction (via causal inference methods) of systematic errors in the biomedical literature.
et al., 2016, Burden of Cancer in a Large Consortium of Prospective Cohorts in Europe, Journal of the National Cancer Institute, Vol:108, ISSN:0027-8874
et al., 2015, Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies, British Medical Journal, Vol:350, ISSN:1756-1833
et al., 2015, A Genome-wide Pleiotropy Scan for Prostate Cancer Risk, European Urology, Vol:67, ISSN:0302-2838, Pages:649-657
et al., 2012, Evaluation of Excess Statistical Significance in Meta-analyses of 98 Biomarker Associations with Cancer Risk, Journal of the National Cancer Institute, Vol:104, ISSN:0027-8874, Pages:1867-1878
et al., 2014, Metformin Does Not Affect Cancer Risk: A Cohort Study in the UK Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial, Diabetes Care, Vol:37, ISSN:0149-5992, Pages:2522-2532